Abstract The Fc portion of immunoglobulin G (IgG) recruits complements and its cognate receptors, thereby promoting defensive mechanisms in the humoral immune system. These effector functions critically depend on Nglycosylation at the Fc region, which is therefore regarded as a crucial factor in the design and production of therapeutic antibodies. NMR spectroscopy plays a unique role in the characterization of conformational dynamics and intermolecular interactions of IgG-Fc in solutions. Here, we report NMR assignments of the glycosylated Fc fragment (Mr 53 kDa), cleaved from a chimeric antibody with human IgG1 constant regions, which was produced in Chinese hamster ovary cells with uniform 13 C-and 15 Nlabeling.
Biological context
Immunoglobulin G (IgG) is a multifunctional glycoprotein composed of an Fc region and two Fab regions, which are connected through the hinge region ). The Fab regions recognize and capture specific antigens, while the Fc region recruits complements and its cognate receptors, Fcc receptors (FccRs), and offers acceptor sites for bacterial proteins including protein A and protein G. The Fc region has a homodimeric structure comprising the C-terminal halves of the heavy chains, each composed of the C H 2 and C H 3 domains. The C H 2 domain possesses a conserved N-glycosylation site, Asn297, at which a biantennary complex-type oligosaccharide is expressed with microheterogenieties characterized by the presence and absence of the non-reducing terminal galactose, fucose, sialic acid, and bisecting N-acetylglucosamine residues.
The effector function of IgG critically depends on Nglycosylation in the Fc region. The outer carbohydrate moieties govern the structural integrity of the FccR-binding site of IgG, while the core fucosylation impairs antibody-dependent cellular cytotoxicity because of its negative steric effect against IgG interaction with FccRIII (Ferrara et al. 2011; Krapp et al. 2003; Mizushima et al. 2011; Yamaguchi et al. 2006) . Hence, the Fc glycoforms are now considered as a crucial factor in the design and Hirokazu Yagi and Ying Zhang have contributed equally to this work.
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NMR spectroscopy offers unique tools for characterizing the conformational dynamics and intermolecular interactions of IgG-Fc in solution (Kato et al. 1991a (Kato et al. , 1993a (Kato et al. , 1995 Kim et al. 1994a; Latypov et al. 2012) . We developed protocols for uniform and amino acid-selective stable isotope labeling of an IgG glycoprotein and its functional fragments, using mammalian expression systems (Kato et al. 2010; Yamaguchi and Kato 2010) . Based on partially (approximately 66 %) achieved spectral assignments (Yamaguchi et al. 2006) , we previously reported NMR analytical results to characterize the Nglycosylation-dependent conformational changes of human IgG1-Fc and its interaction with a specific RNA aptamer (Matsumiya et al. 2007; Miyakawa et al. 2008; Yamaguchi et al. 2006) .
In an extension of these studies, we herein report NMR assignments of the glycosylated version of Fc fragment (Mr 53 kDa) cleaved from a chimeric antibody with human IgG1 constant regions that was expressed by Chinese hamster ovary (CHO) cells with uniform 13 C-and 15 Nlabeling.
Methods and experiments
The CHO/DG44 cell line (Urlaub1980) was kindly provided by Dr. Lawrence Chasin (Columbia University, NY). An anti-CCR4 chimeric antibody (designated KM3060), with human IgG1/j constant regions, was produced in a CHO cell line as described previously (Yamaguchi and Kato 2010; Yamaguchi et al. 2006) . The CHO cells were cultivated using the Nissui NYSF 404 medium supplemented with 2 % dialyzed fetal bovine serum. At the final stage of cell culture, the medium was replaced with an isotopically labeled one with 2 % dialyzed fetal bovine serum. Uniformly 15 N/ 13 Clabeled IgG1 was prepared using a modified Nissui NYSF 404 medium (supplemented with 2 % dialyzed fetal bovine serum) in which glucose, sodium pyruvate, succinic acid, and amino acids were replaced by 1 g/ Trp. Amino acid-selective labeling of IgG1 was performed using the modified Nissui NYSF 404 medium (supplemented with 2 % dialyzed fetal bovine serum) in which selected amino acid components were substituted with isotopically labeled analogs, as described previously (Kato et al. 1991a (Kato et al. , b, 1993b Kim et al. 1994b) . After cell growth, the supernatant was purified using an Affi-gel protein A column (GE Healthcare Bio-Sciences), as described previously (Yamaguchi et al. 1995) . The Fc fragment of IgG1 was prepared by papain digestion, performed at 37°C for 12 h in 75 mM sodium phosphate buffer (pH 7.0) containing 75 mM NaCl, and 2 mM EDTA. The protein concentration was 10 mg/ml, and the ratio of papain/IgG1 was 1:50 (w:w). The digestion products were loaded onto an Affi-gel protein A column. To prepare IgG1-Fc exhibiting a homogeneous N-glycan, GlcNAcb1-2Mana1-3(GlcNAcb1-2Mana1-6)Manb1-4Glc-NAcb1-4(Fuca1-6)GlcNAc, the Fc fragment was treated with a recombinant Streptococcus pneumoniae b1,4-galactosidase (CALBIOCHEM), according to the literature (Yamaguchi et al. 2006) .
For NMR measurements, the Fc fragment was dissolved in 0.5 ml of 5 mM sodium phosphate buffer (pH 6.0) containing 50 mM NaCl and 10 % (v/v) D 2 O. NMR spectra were acquired at 42 or 52°C using DMX500 (Bruker BioSpin), AVANCE800 (Bruker BioSpin), and ECA-920 (JEOL) spectrometers. Chemical shifts of Backbone resonance assignments were made on the basis of 2D 1 H-15 N HSQC spectral data of uniformly or selectively 13 C/ 15 N-labeled IgG1-Fc, and 3D spectral data obtained with the following experiments: HNCA, HNCO, HN(CA)CO, CBCA(CO)NH, and HNCACB. All NMR data were processed using NMRPipe software (Delaglio et al. 1995) , and analyzed with SPARKY (Goddard and Kneller 1993) and CcpNmr (Vranken et al. 2005) software. Figure 1 shows the 1 H-15 N HSQC spectrum of human IgG1-Fc. Although the use of a mammalian expression system is mandatory for preparing antibodies with physiological glycosylation, uniform deuteration of the glycoprotein is not facile in such a system (Liu et al. 2007 ). Hence, we established spectral assignments based on the triple resonance spectral dataset recorded at a higher temperature, i.e. 52°C, complemented with HSQC spectral data obtained by amino acid-selective 13 C/ 15 N-labeling. Chemical shift assignments were made for protein backbone resonances: Ca (99 %), Cb (84 %), CO (80 %), HN (99 %), and N (99 %) (except for N of prolines). The spectral assignments at lower temperatures could be extrapolated by observing progressive spectral changes, depending on temperature, as exemplified by the spectrum at 42°C (Supplemental Fig.1 ). The present spectral assignments indicate that a cluster of amino acid residues in the vicinity of the N-glycans, i.e. Gln295-Thr299 exhibit 
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